NDRA
ENDRA Life Sciences Inc

11,047
Loading...
Loading...
News
all
press releases
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), today reported financial results for the three and nine months ended September 30, 2024 and provided...
Business Wire·11mo ago
News Placeholder
More News
News Placeholder
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be Presented at AASLDs The Liver Meeting 2024
ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS), today announced the acceptance of a poster titled Noninvasive assessment of steatotic liver...
Business Wire·11mo ago
News Placeholder
ENDRA Life Sciences Further Strengthens TAEUS Platform Intellectual Property with Issuance of 17th European Patent
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), announces that the European Patent Office has issued to ENDRA a new patent EP4247282 (the 282...
Business Wire·11mo ago
News Placeholder
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
ENDRA Life Sciences shares are trading higher by 147% Tuesday. The company announced the activation of a post market clinical study of the TAEUS liver system. read more...
Benzinga·11mo ago
News Placeholder
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), announces the activation of a post market clinical study and first patient scanned with the TAEUS...
Business Wire·11mo ago
News Placeholder
ENDRA Life Sciences Strives for Nasdaq Compliance
ENDRA Life Sciences (NDRA) just unveiled an announcement. ENDRA Life Sciences Inc. has announced that they've received additional time from a Nasda...
TipRanks Financial Blog·1y ago
News Placeholder
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), today announced that on August 27, 2024, the Company was notified by The Nasdaq Stock Market LLC...
Business Wire·1y ago
News Placeholder
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), reports financial results for the three and six months ended June 30, 2024, as filed in a Form 10-Q...
Business Wire·1y ago
News Placeholder
ENDRA Life Sciences Announces Reverse Stock Split
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), today announced that it will implement a 1-for-50 reverse stock split of the issued shares...
Business Wire·1y ago
News Placeholder
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), today announced that it will host a conference call and webcast beginning at 4:30 p.m...
Business Wire·1y ago

Latest NDRA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.